NeoGenomics, Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-396.0K | $-6.1M | $-2.5M | $1.1M | $2.0M | $65.0K | $-1.2M | $-3.3M |
| Depreciation & Amortization | $15.6M | $15.9M | $6.7M | $5.3M | $4.2M | $3.6M | — | — |
| Depreciation | $15.6M | $15.9M | $6.7M | $5.3M | $4.2M | $3.6M | $2.1M | $1.8M |
| Amortization | $7.0M | $7.3M | $412.0K | $295.0K | $223.0K | $182.0K | — | — |
| Stock-Based Compensation | $6.4M | $5.4M | $3.5M | $641.0K | $666.0K | $645.0K | — | — |
| Net Cash from Operating Activities | $18.0M | $21.5M | $6.4M | $9.5M | $2.2M | $-492.0K | $69.0K | $-2.1M |
| Investing Activities | ||||||||
| Capital Expenditures | $13.7M | $7.5M | $2.2M | $3.8M | $2.0M | $2.6M | $897.0K | $916.0K |
| Business Acquisitions | $0 | $-1.0M | $72.9M | $5.8M | — | — | — | — |
| Net Cash from Investing Activities | $-13.7M | — | — | — | $-2.0M | $-3.7M | $-897.0K | $-916.0K |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $-4.1M | — | — | — | $2.8M | $3.4M | $2.4M | $2.4M |
| Net Change in Cash | $296.0K | $-10.9M | $-10.3M | $28.9M | $3.0M | $-760.0K | $1.5M | $-534.0K |
| Free Cash Flow | $4.3M | $13.9M | $4.2M | $5.7M | $216.0K | $-3.1M | $-828.0K | $-3.0M |